Energy Transfer Catalysis Enabled by Multichannel Through‐Space Charge Transfer TADF Photosensitizers: [2 + 2] Photocycloaddition to Cyclobutane‐Fused Phosphindole 3‐Oxides
Angewandte Chemie International Edition · 05.10.2026 · 65 (41)
DOI: 10.1002/anie.1444773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 10.08.2026. Verfasst von Jingjing Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, People's Republic of Ch…. Die Arbeit nennt 133 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Triplet energy transfer (TEnT) photocatalysis has emerged as a powerful tool for enabling mild and selective bond‐forming reactions. However, its generality remains limited by the intrinsic trade‐offs in existing photosensitizers (PSs). Noble metal (e.g., Ir, Ru) complexes offer high efficiency yet suffer from cost and sustainability concerns, while organic carbonyl sensitizers suffer from weak visible‐light absorption and short‐lived triplet states. Herein, we report heavy‐atom‐free organic PSs featuring a multi‐channel through‐space charge transfer (TSCT) architecture within a thermally activated delayed fluorescence (TADF) framework. A highly twisted donor‐acceptor topology enforces near‐complete frontier orbital separation, leading to ultralow singlet‐triplet energy gaps (Δ E ST down to 0.013 eV) and thereby enabling efficient spin interconversion. Consequently, these PSs simultaneously achieve high intersystem crossing (ISC) quantum yields, microsecond‐scale triplet lifetimes, and high triplet energies ( E T up to 63.7 kcal mol −1 ), rivaling those of state‐of‐the‐art noble‐metal systems. Leveraging these features, we demonstrate the first visible‐light‐driven intermolecular [2 + 2] cycloaddition of 1,3‐diphenylphosphindole 1‐oxides with alkenes and alkynes, enabling rapid access to structurally complex cyclobutane‐fused phosphindole 3‐oxides that hold potential value in drug screening but are typically difficult to obtain. Mechanistic studies support a TEnT pathway, in which minimal Δ E ST and efficient ISC are key to achieving high TEnT reactivity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, People's Republic of China.
ORCID-Profile: Jingjing Zhang, Jingbo Lan, Jingsong You, Guangying Tan
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Sichuan Science and Technology Program
- TCL Science and Technology Innovation Fund
Zitieren
APA
Zhang, J., Li, D., Tang, Y., Li, R., Sun, H., Li, X., Lan, J., You, J., & Tan, G. (2026). Energy Transfer Catalysis Enabled by Multichannel Through‐Space Charge Transfer TADF Photosensitizers: [2 + 2] Photocycloaddition to Cyclobutane‐Fused Phosphindole 3‐Oxides. Angewandte Chemie International Edition, 65(41). https://doi.org/10.1002/anie.1444773
Vancouver
Zhang J, Li D, Tang Y, Li R, Sun H, Li X, et al. Energy Transfer Catalysis Enabled by Multichannel Through‐Space Charge Transfer TADF Photosensitizers: [2 + 2] Photocycloaddition to Cyclobutane‐Fused Phosphindole 3‐Oxides. Angewandte Chemie International Edition. 2026;65(41). doi:10.1002/anie.1444773
BibTeX
@article{Zhang2026,
author = {Zhang, Jingjing and Li, Dongle and Tang, Yuyang and Li, Ruobing and Sun, Haozheng and Li, Xin and Lan, Jingbo and You, Jingsong and Tan, Guangying},
title = {Energy Transfer Catalysis Enabled by Multichannel Through‐Space Charge Transfer TADF Photosensitizers: [2 + 2] Photocycloaddition to Cyclobutane‐Fused Phosphindole 3‐Oxides},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {41},
doi = {10.1002/anie.1444773}
}
EUVIMED